Is CorMedix Inc. overvalued?

CorMedix Inc. (CRMD) — key valuation metrics and fundamentals.

No verdict

Price

$7.89

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$619.0M

Dividend yield

0.0%

Return on equity

44.6%

Sector

Healthcare

Fair value compares CRMD's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks